QIAN; Xueming

Patent Applications and Registrations

Patent applications and USPTO patent grants for QIAN; Xueming.The latest application filed is for "novel anti-cldn18.2 antibodies".

Company Profile

5.10.18

QIAN; Xueming - Suzhou Jiangsu
QIAN; Xueming - Lianyungang CN
QIAN; Xueming - Thousand Oaks CA
Qian; Xueming - Beijing CN
Qian; Xueming - Oaks Park CA
Qian; Xueming - Oak Park CA
Qian; Xueming - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Novel Anti-cldn18.2 Antibodies App 20220306765 - QIAN; Xueming ; et al.	2022-09-29
Anti-cd40 Antibody, Antigen Binding Fragmentand Pharmaceutical Use Thereof App 20220025060 - LIAO; Cheng ; et al.	2022-01-27
Human Il-4r Binding Antibody, Antigen Binding Fragment Thereof, And Medical Use Thereof App 20210238294 - LIAO; Cheng ; et al.	2021-08-05
Novel Anti-pd-l1 Antibodies App 20210009693 - QIAN; Xueming ; et al.	2021-01-14
Anti-PD-L1 antibodies Grant 10,822,416 - Qian , et al. November 3, 2	2020-11-03
Anti-cd40 Antibody, Antigen Binding Fragment Thereof And Medical Use Thereof App 20200148778 - Yan; Shude ; et al.	2020-05-14
Novel Anti-pd-l1 Antibodies App 20190330348 - QIAN; Xueming ; et al.	2019-10-31
Antibodies and methods for treating estrogen receptor-associated diseases Grant 10,233,249 - Qian , et al.	2019-03-19
Therapeutic human anti-IL-1R1 monoclonal antibody Grant 9,534,053 - Varnum , et al. January 3, 2	2017-01-03
Antibodies And Methods For Treating Estrogen Receptor-associated Diseases App 20160046721 - QIAN; Xueming ; et al.	2016-02-18
Therapeutic Human Anti-il-1r1 Monoclonal Antibody App 20140335099 - Varnum; Brian ; et al.	2014-11-13
Therapeutic human anti-IL-1R1 monoclonal antibody Grant 8,710,203 - Varnum , et al. April 29, 2	2014-04-29
Therapeutic Human Anti-il-1r1 Monoclonal Antibody App 20140039164 - Varnum; Brian ; et al.	2014-02-06
Therapeutic human anti-IL-1R1 monoclonal antibody Grant 8,518,407 - Varnum , et al. August 27, 2	2013-08-27
Wise Binding Agents And Epitopes App 20120288507 - Qian; Xueming ; et al.	2012-11-15
Wise binding agents and epitopes Grant 8,309,092 - Qian , et al. November 13, 2	2012-11-13
Therapeutic Human Anti-il-1r1 Monoclonal Antibody App 20120269824 - Varnum; Brian ; et al.	2012-10-25
Therapeutic human anti-IL-1R1 monoclonal antibody Grant 8,236,559 - Varnum , et al. August 7, 2	2012-08-07
Single Matching Network For Matching Multi-frequency And Method Of Constructuring The Same And Radio Frequency Power Source System Using The Same App 20120075033 - OUYANG; Liang ; et al.	2012-03-29
Wise Binding Agents And Epitopes App 20120003237 - QIAN; Xueming ; et al.	2012-01-05
Wise binding agents and epitopes Grant 8,043,620 - Qian , et al. October 25, 2	2011-10-25
Therapeutic Human Anti-IL-1R1 Monoclonal Antibody App 20090214559 - Varnum; Brian ; et al.	2009-08-27
Wise Binding Agents And Epitopes App 20090130114 - Qian; Xueming ; et al.	2009-05-21
Therapeutic human anti-IL1-R1 monoclonal antibody Grant 7,438,910 - Varnum , et al. October 21, 2	2008-10-21
Screening method for antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof App 20050084493 - Witte, Alison ; et al.	2005-04-21
Therapeutic human anti-IL1-R1 monoclonal antibody App 20040097712 - Varnum, Brian ; et al.	2004-05-20
Antibodies and other selective IL-1 binding agents that allow binding to IL-1 receptor but not activation thereof App 20030026806 - Witte, Alison ; et al.	2003-02-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.